Publication:
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis.

cris.virtual.author-orcid0000-0003-4562-9016
cris.virtual.author-orcid0000-0003-4595-4724
cris.virtualsource.author-orcida4094c89-e546-4ec5-8814-a2e707b77691
cris.virtualsource.author-orcidd590805e-3cc5-435a-a687-b8b2041aeaf8
datacite.rightsrestricted
dc.contributor.authorPennisi, Grazia
dc.contributor.authorEnea, Marco
dc.contributor.authorRomero-Gomez, Manuel
dc.contributor.authorViganò, Mauro
dc.contributor.authorBugianesi, Elisabetta
dc.contributor.authorWong, Vincent W-S
dc.contributor.authorFracanzani, Anna Ludovica
dc.contributor.authorSebastiani, Giada
dc.contributor.authorBoursier, Jerome
dc.contributor.authorBerzigotti, Annalisa
dc.contributor.authorEslam, Mohammed
dc.contributor.authorAmpuero, Javier
dc.contributor.authorBenmassaoud, Amine
dc.contributor.authorLa Mantia, Claudia
dc.contributor.authorMendoza Jaimes, Yuly Paulin
dc.contributor.authorGeorge, Jacob
dc.contributor.authorCraxì, Antonio
dc.contributor.authorCamma', Calogero
dc.contributor.authorde Ledinghen, Victor
dc.contributor.authorPetta, Salvatore
dc.date.accessioned2024-10-14T22:46:03Z
dc.date.available2024-10-14T22:46:03Z
dc.date.issued2022-03
dc.description.abstractBACKGROUND & AIM Non-alcoholic fatty liver disease (NAFLD), and especially fibrotic non-alcoholic steatohepatitis, is associated with high risks of liver-related events (LRE) and extrahepatic events (EHE). We evaluated the competitive risk occurrence of LRE and EHE in a large cohort of biopsy-proven NAFLD stratified according to baseline severity of fibrosis. METHODS Two thousand one hundred thirty-five patients with biopsy-proven NAFLD were enrolled. Observed cumulative incidence functions (CIFs) were used to evaluate the risk of LRE and EHE; cause-specific Cox model and predicted CIFs were fitted to identify predictors of LRE and EHE. A replication cohort of NAFLD patients with liver fibrosis severity estimated by liver stiffness measurement by transient elastography was also enrolled. RESULTS Observed CIFs indicated that the 60-month probabilities of LRE and EHE were 0.2% and 3% in F0-F1, 2% and 3.8% in F2 and 9.7% and 6.4% in F3-F4 patients, respectively. The cause-specific Cox model indicated that in F0-F1 and F2 patients, age > 50 years (HR 2.7) was the only predictor of LRE, while age > 50 years (HR 2.96), previous cardiovascular events (CVE, HR 2.07), and previous extra-hepatic cancer (HR 2.36) were independent risk factors for EHE. In F3-F4 patients, age > 55 years (HR 1.73), obesity (HR 1.52), PLT < 150 000/mmc (HR 3.66) and log(GGT) (HR 1.77) were associated with LRE, while age > 55 years (HR 1.74) and previous CVE (HR 2.51) were independent predictors of EHE. Predicted CIFs for HE and EHE in F0-F1, F2 and F3-F4 patients stratified the risk of events. The results were externally replicated. CONCLUSION The likelihood of EHE in NAFLD patients is relevant and increases according to the severity of liver fibrosis, while the risk of LRE is negligible in F0-F1, low but clinically relevant in F2 and high in F3-F4 patients.
dc.description.numberOfPages12
dc.description.sponsorshipUniversitätsklinik für Viszerale Chirurgie und Medizin, Hepatologie
dc.description.sponsorshipUniversitätsklinik für Viszerale Chirurgie und Medizin
dc.identifier.doi10.48350/175754
dc.identifier.pmid34988994
dc.identifier.publisherDOI10.1111/apt.16763
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/116064
dc.language.isoen
dc.publisherWiley-Blackwell
dc.relation.ispartofAlimentary pharmacology & therapeutics
dc.relation.issn0269-2813
dc.relation.organizationDCD5A442BBC5E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C1F6E17DE0405C82790C4DE2
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleLiver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage615
oaire.citation.issue5
oaire.citation.startPage604
oaire.citation.volume55
oairecerif.author.affiliationUniversitätsklinik für Viszerale Chirurgie und Medizin, Hepatologie
oairecerif.author.affiliationUniversitätsklinik für Viszerale Chirurgie und Medizin
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2022-12-14 14:22:54
unibe.description.ispublishedpub
unibe.eprints.legacyId175754
unibe.journal.abbrevTitleALIMENT PHARM THER
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
Aliment_Pharmacol_Ther_-_2022_-_Pennisi_-_Liver_related_and_extrahepatic_events_in_patients_with_non_alcoholic_fatty_liver.pdf
Size:
1.11 MB
Format:
Adobe Portable Document Format
File Type:
text
License:
publisher
Content:
published

Collections